Taysha Gene Therapies, Inc.

NasdaqGS:TSHA Stock Report

Market Cap: US$531.1m

Taysha Gene Therapies Balance Sheet Health

Financial Health criteria checks 5/6

Taysha Gene Therapies hat ein Gesamteigenkapital von $-49.1M und eine Gesamtverschuldung von $38.5M, was einen Verschuldungsgrad von -78.5% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $195.8M bzw. $244.9M.

Key information

54.1%

Debt to equity ratio

US$40.51m

Debt

Interest coverage ration/a
CashUS$143.94m
EquityUS$74.94m
Total liabilitiesUS$97.79m
Total assetsUS$172.73m

Recent financial health updates

We're Hopeful That Taysha Gene Therapies (NASDAQ:TSHA) Will Use Its Cash Wisely

Mar 08
We're Hopeful That Taysha Gene Therapies (NASDAQ:TSHA) Will Use Its Cash Wisely

Recent updates

What Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) 55% Share Price Gain Is Not Telling You

Mar 21
What Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) 55% Share Price Gain Is Not Telling You

Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts

Mar 20

Taysha: Produces Solid Data But Has Abandoned Programs

Feb 06

Taysha Gene Therapies Gets A 'Thumbs Up'

Mar 07

We're Hopeful That Taysha Gene Therapies (NASDAQ:TSHA) Will Use Its Cash Wisely

Mar 08
We're Hopeful That Taysha Gene Therapies (NASDAQ:TSHA) Will Use Its Cash Wisely

Taysha and UT Southwestern Medical Center launch innovation fund in gene therapy development push

Jan 13

Taysha teams up with AllStripes to advance gene therapy in rare disorder

Jan 04

What Kind Of Shareholders Hold The Majority In Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) Shares?

Dec 24
What Kind Of Shareholders Hold The Majority In Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) Shares?

Taysha on go with early-stage study with its gene therapy in inherited lysosomal storage disorder

Dec 21

Financial Position Analysis

Kurzfristige Verbindlichkeiten: TSHADie kurzfristigen Aktiva des Unternehmens ($149.9M) übersteigen seine kurzfristigen Passiva ($36.8M).

Langfristige Verbindlichkeiten: TSHADie kurzfristigen Vermögenswerte des Unternehmens ($149.9M) übersteigen seine langfristigen Verbindlichkeiten ($61.0M).


Debt to Equity History and Analysis

Verschuldungsgrad: TSHA über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob das Verhältnis von Schulden zu Eigenkapital in den letzten 5 Jahren gesunken ist ( TSHA).


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stabile Start- und Landebahn für Bargeld: TSHA auf der Grundlage seines derzeitigen freier Cashflows über eine ausreichende Liquiditätsreserve für mehr als ein Jahr verfügt.

Vorhersage Cash Runway: TSHA verfügt über eine ausreichende Liquiditätsreserve für 2.4 Jahre, wenn der freie Cashflow weiterhin mit historischen Raten von 19% pro Jahr abnimmt.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.